Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

2 results
Results by year
Filters applied: . Clear all
Page 1
Your search for Evaluation of chemicals requiring metaboli c activation in the EpiDerm™ 3D human reconstructed skin micronucleus (RSMN) assay retrieved no results
Evaluation of chemicals requiring metabolic activation in the EpiDerm 3D human reconstructed skin micronucleus (RSMN) assay.
Aardema MJ, Barnett BB, Mun GC, Dahl EL, Curren RD, Hewitt NJ, Pfuhler S. Aardema MJ, et al. Mutat Res. 2013 Jan 20;750(1-2):40-9. doi: 10.1016/j.mrgentox.2012.08.009. Epub 2012 Sep 27. Mutat Res. 2013. PMID: 23022594
The in vitro human reconstructed skin micronucleus (RSMN) assay in EpiDerm is a promising new assay for evaluating genotoxicity of dermally applied chemicals. ...While further work with chemicals that …
The in vitro human reconstructed skin micronucleus (RSMN) assay in EpiDerm is a promising n …
The 3D reconstructed skin micronucleus assay: considerations for optimal protocol design.
Kidd D, Phillips S, Chirom T, Mason N, Smith R, Saul J, Whitwell J, Clements J. Kidd D, et al. Mutagenesis. 2021 Apr 28;36(1):37-49. doi: 10.1093/mutage/gez037. Mutagenesis. 2021. PMID: 31793640
Implementation of the seventh amendment to the EU Cosmetics Directive has driven much research into suitable in vitro alternative assays to support satisfactory risk assessments. One such assay is the reconstructed skin micronucleus (RSMN
Implementation of the seventh amendment to the EU Cosmetics Directive has driven much research into suitable in vitro alternative assays